[1]肖 穷.二羟丙茶碱治疗慢性阻塞性肺疾病的临床疗效及不良反应观察[J].医学信息,2024,37(15):130-133.[doi:10.3969/j.issn.1006-1959.2024.15.030]
　XIAO Qiong.Observation of Clinical Efficacy and Adverse Reactions of Diprophylline in the Treatment of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2024,37(15):130-133.[doi:10.3969/j.issn.1006-1959.2024.15.030]
点击复制

二羟丙茶碱治疗慢性阻塞性肺疾病的临床疗效及不良反应观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年15期
页码:
130-133
栏目:
论著
出版日期:
2024-08-01

文章信息/Info

Title:
Observation of Clinical Efficacy and Adverse Reactions of Diprophylline in the Treatment of Chronic Obstructive Pulmonary Disease
文章编号:
1006-1959（2024）15-0130-04
作者:
肖 穷
（湖口县人民医院呼吸内科，江西 湖口 332500）
Author(s):
XIAO Qiong
(Department of Respiratory Medicine,Hukou County People’s Hospital,Hukou 332500,Jiangxi,China)
关键词:
慢性阻塞性肺疾病; 二羟丙茶碱; 症状缓解; 不良反应
Keywords:
Chronic obstructive pulmonary disease; Diprophylline; Remission; Adverse reactions
分类号:
R563.9
DOI:
10.3969/j.issn.1006-1959.2024.15.030
文献标志码:
A
摘要:
目的 研究二羟丙茶碱治疗慢性阻塞性肺疾病（COPD）的临床疗效及不良反应。方法 选取2023年1月-6月湖口县人民医院收治的60例COPD患者，经随机数字表法分为对照组（30例）与观察组（30例）。对照组行常规对症治疗，观察组在其基础上加用二羟丙茶碱治疗，比较两组临床疗效、症状缓解时间（喘息、咳嗽、咳痰）、病情改善情况[COPD患者自我评估测（CAT）、圣·乔治医院呼吸问题调查问卷（SGRQ）评分]、不良反应。结果 观察组治疗有效率高于对照组（P＜0.05）；观察组症状（喘息、咳嗽、咳痰）缓解时间短于对照组（P＜0.05）；两组治疗后CAT、SGRQ评分低于治疗前，且观察组CAT、SGRQ评分低于对照组（P＜0.05）；两组不良反应发生率比较，差异无统计学意义（P＞0.05）。结论 二羟丙茶碱在COPD患者中具有确切治疗作用，可提高其临床疗效，加速症状缓解，促进病情转归，且具有良好用药安全性。
Abstract:
Objective To study the clinical efficacy and adverse reactions of diprophylline in the treatment of chronic obstructive pulmonary disease (COPD).Methods Sixty patients with COPD admitted to Hukou County People’s Hospital from January to June 2023 were selected and divided into control group (30 patients) and observation group (30 patients) by random number table method. The control group was treated with routine symptomatic treatment, and the observation group was treated with diprophylline on the basis of the control group. The clinical efficacy, symptom relief time (wheezing, cough, sputum), improvement of the disease [COPD assessment test (CAT), St.George’s Hospital Respiratory Questionnaire (SGRQ) score] and adverse reactions were compared between the two groups.Results The effective rate of treatment in the observation group was higher than that in the control group (P<0.05). The remission time (wheezing, cough, sputum) in the observation group was shorter than that in the control group (P<0.05). The scores of CAT and SGRQ in the two groups after treatment were lower than those before treatment, and the scores of CAT and SGRQ in the observation group were lower than those in the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion Diprophylline has a definite therapeutic effect in patients with COPD, which can improve its clinical efficacy, accelerate symptom relief, promote disease outcome, and has good drug safety.

参考文献/References:

[1]白俊东,姚华强,张玉娜,等.头孢他啶联合氨茶碱治疗慢性阻塞性肺气肿的疗效及对血清IGF-1、α1-AT、PDGF-B水平的影响[J].现代生物医学进展,2019,19(9):1762-1765.[2]Patentalakis G,Bakakos P,Papaporfyriou A,et al.Asthma-chronic obstructive pulmonary disease overlap: Diagnostic stability and inflammatory characteristics[J].Allergy,2019,74(11):2271-2273.[3]王立婧,单淑香,冯丽君.多索茶碱对老年慢性阻塞性肺疾病患者血清中TGF-β1、NF-κB的影响及与预后的关系[J].广东医学,2020,41(19):2041-2044.[4]李芳,程玉峰,吴成明,等.沙丁胺醇联合二羟丙茶碱治疗慢性阻塞性肺疾病急性加重期的临床研究[J].现代药物与临床,2020,35(6):1171-1175.[5]王芳杰,崔虎啸,史广超.三子止咳胶囊联合二羟丙茶碱治疗慢性支气管炎急性发作的临床研究[J].现代药物与临床,2018,33(12):3212-3215.[6]李静,林忠贤,周国红.氨茶碱联合布地奈德福莫特罗对AECOPD患者氧化应激及肺功能的影响[J].海南医学,2020,31(2):167-170.[7]中华医学会呼吸病学分会慢性阻塞性肺疾病学组,中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会.慢性阻塞性肺疾病诊治指南(2021年修订版)[J].中华结核和呼吸杂志,2021,44(3):170-205.[8]韩冲锋.氨茶碱治疗慢阻肺稳定期患者的疗效及对患者生活质量的影响[J].贵州医药,2019,43(6):924-926.[9]何文波,陈兆军.布地奈德气雾剂联合正压通气治疗慢性阻塞性肺疾病急性加重期并发严重呼吸衰竭的临床研究[J].中国临床药理学杂志,2019,35(11):1105-1108.[10]Macdonald MI,Bardin PG.Contemporary Concise Review 2020: Chronic obstructive pulmonary disease[J].Respirology,2021,21(3):658-661.[11]Shukla S,Walters E,Simpson J,et al.Hypoxianducible factor and bacterial infections in chronic obstructive pulmonary disease[J].Respirology,2020,25(1):26-30.[12]陆小华,张学会,沈静妍,等.氨茶碱与多索茶碱对老年慢性阻塞性肺疾病患者气道重塑及血清激活素A、转化生长因子β1水平影响的对比研究[J].实用心脑肺血管病杂志,2018,26(7):70-73.[13]李啸.小剂量氨茶碱联合呼吸功能训练治疗慢性阻塞性肺疾病的临床疗效[J].实用临床医药杂志,2018,22(11):27-29.[14]林敬明,陈文丽,郑辉才,等.对比布地奈德福莫特罗与氨茶碱治疗缓解期COPD的疗效及对患者血气指标、肺功能影响[J].中国急救复苏与灾害医学杂志,2019,14(7):635-638.[15]陈荣.氨茶碱与多索茶碱应用在慢阻肺临床治疗的效果观察[J].湖南中医药大学学报,2018,38(1):366.[16]闫素芳,巴雪峰.清热解毒软胶囊联合多索茶碱对慢阻肺患者免疫功能及动脉血气指标的影响[J].湖北中医药大学学报,2020,22(4):61-63.[17]Yousaf M,Zahoor AF,Faiz S,et al.Recent Synthetic Approaches Towards Biologically Potent Derivatives/Analogues of Theophylline[J].Journal of Heterocyclic Chemistry,2018,55(11):2447-2479.[18]李延琴,杨丽.布地奈德福莫特罗粉吸入剂与氨茶碱片治疗缓解期慢性阻塞性肺疾病的疗效对比观察[J].山西医药杂志,2023,52(5):375-377.[19]徐木生.多索茶碱和氨茶碱治疗慢性阻塞性肺疾病的疗效比较[J].中国药物与临床,2020,20(2):258-260.[20]戴芹,方思,赵玉,等.常规剂量氨茶碱对AECOPD患者血药浓度影响的回顾性分析[J].武汉大学学报(医学版),2021,42(1):151-155.[21]Cazzola M,Calzetta L,Rogliani P,et al.Maria Gabriella.Impact of doxofylline in COPD: A pairwise meta-analysis[J].Pulm Pharmacol Ther,2018,51:1-9[22]黄莹,刘琼娇,龚宗炼.金贝痰咳清颗粒联合二羟丙茶碱治疗老年慢性支气管炎急性发作的效果[J].中国医药导报,2019,16(31):148-151.

相似文献/References:

[1]钟雪梅,李 黎,米热班·热夏提,等.α1-抗胰蛋白酶与维吾尔族慢性阻塞性肺疾病的相关性分析[J].医学信息,2018,31(02):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
　ZHONG Xue-mei,LI Li,Mirban·rixat,et al.Correlation Analysis of α1-antitrypsin and Uygur Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(15):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
[2]陈文福.噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效分析[J].医学信息,2018,31(02):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
　CHEN Wen-fu.Clinical Analysis of Tiotropium Bromide in the Treatment of Stable Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(15):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
[3]吴仲东.无创机械通气用于COPD合并呼吸衰竭的疗效分析[J].医学信息,2018,31(04):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
　WU Zhong-dong.Clinical Analysis of Noninvasive Mechanical Ventilation in Patients with COPD Complicated with Respiratory Failure[J].Journal of Medical Information,2018,31(15):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
[4]龙有珠.氨茶碱联合呼吸功能训练治疗慢性阻塞性肺疾病的疗效分析[J].医学信息,2018,31(04):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
　LONG You-zhu.Effect of Aminophylline Combined with Respiratory Function Training on Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(15):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
[5]皮鑫鑫,邓 革.临床药师对1例院内感染患者的病例分析[J].医学信息,2018,31(04):188.[doi:10.3969/j.issn.1006-1959.2018.04.072]
[6]罗 倩.COPD加重期患者肺功能、血气指标及 炎症指标的变化分析[J].医学信息,2018,31(09):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
　LUO Qian.Changes of Pulmonary Function,Blood Gas and Inflammation in Patients with COPD Exacerbation[J].Journal of Medical Information,2018,31(15):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
[7]赵志国.有创-无创序贯通气疗法治疗慢性阻塞性肺疾病 引发的严重呼吸衰竭的临床研究[J].医学信息,2018,31(11):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
　ZHAO Zhi-guo.Clinical Study of Invasive Non-invasive Sequential Ventilation in Treatment of Severe Respiratory Failure Caused by Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(15):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
[8]金彦青.NPPV治疗慢性阻塞性肺疾病合并 重症呼吸衰竭的临床疗效观察[J].医学信息,2018,31(14):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
　JIN Yan-qing.Clinical Efficacy of NPPV in the Treatment of Chronic Obstructive Pulmonary Disease with Severe Respiratory Failure[J].Journal of Medical Information,2018,31(15):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
[9]张 林,白 俐.扶正化瘀胶囊对慢性阻塞性肺疾病患者炎性因子及 MMP-9、TIMP-1的影响[J].医学信息,2018,31(14):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
　ZHANG Lin,BAI Li.Effect of Fuzheng Huayu Capsule on Inflammatory Factors,MMP-9 and TIMP-1 in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(15):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
[10]张善芳,汤 杰.穴位注射联合沙美特罗替卡松粉吸入剂治疗 慢性阻塞性肺疾病稳定期的临床疗效观察[J].医学信息,2018,31(16):131.[doi:10.3969/j.issn.1006-1959.2018.16.041]
　ZHANG Shan-fang,TANG Jie.Clinical Observation of Acupoint Injection Combined with Salmeterol and Fluticasone Powder Inhalation in the Treatment of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(15):131.[doi:10.3969/j.issn.1006-1959.2018.16.041]

更新日期/Last Update: 1900-01-01